Skip to content

A clinical trial to learn about the effects of JFI447 and how it shows up in scans compared to FFG233 in people with solid tumors

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523665-24-00
Enrollment
22
Registered
2026-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CRC or STS., HR+/HER2- ductal and lobular BC, NSCLC, Patients with metastatic PDAC, TNBC

Interventions

None listed

Sponsors

Novartis Pharma AG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 11, 2026